Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.

Junji Zhang | Yuqian Zhao | Yi Dai | Le Dang | Li Ma | Chunxia Yang | Yang Li | Linghua Kong | Lihui Wei | Shulan Zhang | Jihong Liu | Minrong Xi | Long Chen | Xianzhi Duan | Qing Xiao | Guzhalinuer Abulizi | Guonan Zhang | Ying Hong | Xiaohong Gao | Qi Zhou | Xing Xie | Li Li | Mayinuer Niyazi | Zhifen Zhang | Jiyu Tuo | Yiling Ding | Manfei Si | Fei Chen | Li Song | Youlin Qiao | Jinghe Lang
JAMA oncology | 2021

Evidence is needed regarding the introduction of high-risk human papillomavirus (hrHPV) testing into China's national cervical cancer screening program.

Pubmed ID: 33377903

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


QIAGEN (tool)

RRID:SCR_008539

A commercial organization which provides assay technologies to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

View all literature mentions